Ads
related to: psma pet scan vs mri for cancer detection- Sign Up for Updates
Sign up for updates including new
imaging locations and savings.
- Imaging Site Locator
Locate an existing imaging site or
register a new imaging site.
- Downloadable Resources
Discover downloadable guides for
health care professionals.
- Review Case Studies
Discover case study results
for an imaging agent.
- Sign Up for Updates
Search results
Results from the WOW.Com Content Network
A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand. After injection, imaging of positron emitters such as gallium-68 (68 Ga ...
The extent of cancer spread is assessed by MRI or PSMA scan – a positron emission tomography (PET) imaging technique where a radioactive label that binds the prostate protein prostate-specific membrane antigen is used to detect metastases distant from the prostate.
This 300 patient study conducted at 10 study sites demonstrated superior accuracy of PSMA PET/CT (92% vs 65%), higher significant change in management (28% vs 15%), less equivocal/uncertain imaging findings (7% vs 23%) and lower radiation exposure (10 mSv vs 19 mSv). The study concludes that PSMA PET/CT is a suitable replacement for ...
A gallium scan is a type of nuclear medicine test that uses either a gallium-67 (67 Ga) or gallium-68 (68 Ga) radiopharmaceutical to obtain images of a specific type of tissue, or disease state of tissue. Gallium salts like gallium citrate and gallium nitrate may be used. The form of salt is not important, since it is the freely dissolved ...
Gallium (. 68. Ga) gozetotide. Gallium (68Ga) gozetotide or Gallium (68Ga) PSMA-11 sold under the brand name Illuccix among others, is a radiopharmaceutical made of 68 Ga conjugated to prostate-specific membrane antigen (PSMA) targeting ligand, Glu-Urea-Lys (Ahx)-HBED-CC, used for imaging prostate cancer by positron emission tomography (PET). [10]
Positron emission tomography (PET) [1] is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. Different tracers are used for various imaging ...
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1][2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates. [2] Screening precedes a diagnosis and subsequent treatment.
Piflufolastat F-18. Piflufolastat F-18, sold under the brand name Pylarify among others, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging. [1][4][5] It is given by intravenous injection. [1][4] The most common adverse reactions include headache, altered taste, and fatigue. [4]
Ads
related to: psma pet scan vs mri for cancer detection